Cell Source, Inc., a biotechnology company, engages in developing cell therapy treatments based on the management of immune tolerance. Its lead product is the Veto Cell immune system management technology, which is an immune tolerance biotechnology that enables the selective blocking of immune responses. The company's Veto Cell technology is used in various applications, including treatment of lymphoma, leukemia, and multiple myeloma through facilitation of the stem cell transplantation acceptan...
Industry: Biotechnology
Sector: Healthcare
Phone: 646 416 7896
Fax: 646 416 8001
Address:
57 West 57th Street, Suite 400, New York, United States
